Add like
Add dislike
Add to saved papers

Do all patients with shoulder dislocations need prereduction x-rays?

OBJECTIVE: Some would advocate against routine use of prereduction x-rays for shoulder dislocations. Our objective was to examine the percent of dislocations that also had fractures as a function of age to determine whether there are some decades of life with a sufficiently low risk of fracture to avoid routine prereduction x-rays.

METHODS: This was a retrospective cohort study in 19 New Jersey and New York emergency departments. We used The International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9) codes to identify patients with shoulder dislocations and, among these, those who also had fractures. A priori, we chose to group the patients by decade of life. For patients with dislocations in each age group, we calculated the percent that also had fractures.

RESULTS: Of the total 5,408,837 visits in the database, there were 7209 patients with dislocations, of which 465 (6.5%) had fractures. We found the lowest percent of fractures in the 2nd and 3rd decades of life (0.7% [95% confidence interval, 0.3%-1.2%] and 0.8% [0.4%-1.3%]). In the 4th and 5th decades of life, the percents were 2.6% (1.7%-3.5%) and 4.6% (3.2-6.0%), respectively, and they steadily increased to 19% or greater in the 8th to 10th decades of life. Omitting the prereduction x-rays for patients in the 2nd and 3rd decades of life would reduce the total number of prereduction x-rays by 40%.

CONCLUSION: In the second and third decades of life, less than 1% of patients with shoulder dislocations also had fractures. Because these patients have a sufficiently low risk of fracture, routine prereduction x-rays may not be necessary for them.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app